TheProfitWatch

CRIS - Curis Inc

Day 1m 10m 60m PreMarket Market AfterHours Gap
1.13 0.03 (2.65%) --- --- 0.0 (0.0%) --- 0.03 (2.65%) 0.0 (0.0%) 0.0 (0.0%)

Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Market Period: Market

Earnings & Ratios

Basic EPS:
-0.68
Diluted EPS:
-0.68
Basic P/E:
-1.7059
Diluted P/E:
-1.7059
RSI(14) 1m:
50.0
VWAP:
1.15
RVol:

Events

Period Kind Movement Occurred At

Related News